Pharma Reviews: January 2019

Thursday, January 31, 2019

Product Recall Alerts: Recall Alert: Ibuprofen Sold at Walmart and CVS Could Result In Severe Vomiting and Bleeding

Tris Pharma has recalled additional lots of over-the-counter 'Infants Ibuprofen Concentrated Oral Suspension' medication, which may contain ...
Read more: Recall Alert: Ibuprofen Sold at Walmart and CVS Could Result In Severe Vomiting and Bleeding

Product Recall Alerts: Drug maker expands recall for infant ibuprofen over dosage concern

Drug maker expands recall for infant ibuprofen over dosage concern. By ... The decision to recall the drugs was based on an evaluation by the Food and Drug ... "Now they will be able to alert authorities the next time they see them.".
Read more: Drug maker expands recall for infant ibuprofen over dosage concern

Product Recall Alerts: Infant ibuprofen voluntary recall expanded to 3 more products

... lots of infant liquid ibuprofen have been included in a voluntary recall because of concerns there are higher levels of concentration for the medicine, ...
Read more: Infant ibuprofen voluntary recall expanded to 3 more products

Product Recall Alerts: RECALL ALERT: Baby ibuprofen recalled for high drug concentration

AUSTIN (KXAN) — A recall of ibuprofen for babies from November has been expanded by the Food and Drug Administration Thursday, according to a ...
Read more: RECALL ALERT: Baby ibuprofen recalled for high drug concentration

Product Recall Alerts: Pharmaceutical company doubles recall of infant ibuprofen

Infants already susceptible to the adverse effects of ibuprofen may be at a slightly higher risk if given medication from one of the recalled bottles.
Read more: Pharmaceutical company doubles recall of infant ibuprofen

Pharma Reviews: Culture of 'bending rules' in India challenges US drug agency

“I don't think everything's fine, and I'm upset about it, but there's not much you can do,” because India's low production costs makes its pharma industry ...
Read more: Culture of 'bending rules' in India challenges US drug agency

Pharma Reviews: Pre-Budget Expectations: We expect FDI relaxation in the e-pharma sector

Pre-Budget Expectations: We expect FDI relaxation in the e-pharma sector ... will provide the much-needed push to the startup ecosystem in India.
Read more: Pre-Budget Expectations: We expect FDI relaxation in the e-pharma sector

Pharma Reviews: Budget 2019 Expectations from Modi govt: Income Tax bonanza, 7th Pay Commission, Section ...

Budget 2019 Expectations for startups, fintech companies: Rohan Kumar CEO of .... We acknowledge that the pharmaceutical sector of India has joint ...
Read more: Budget 2019 Expectations from Modi govt: Income Tax bonanza, 7th Pay Commission, Section ...

Wednesday, January 30, 2019

Pharma Reviews: Why the 'angel tax' has left early-stage investors exasperated in India

Gururaj Potnis, who cut his teeth in outsourcing, is building HappiDoc, which uses machine learning to help the global pharma industry connect with ...
Read more: Why the 'angel tax' has left early-stage investors exasperated in India

Product Recall Alerts: CONSUMER ALERT: Company expands recall of kids ibuprofen sold at CVS, Walmart & Family ...

(Edited News Release) -- Tris Pharma, Inc. is expanding the scope of its ... CVS offers it under the “CVS Health” label, with the recalled products ...
Read more: CONSUMER ALERT: Company expands recall of kids ibuprofen sold at CVS, Walmart & Family ...

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on 2019 efforts to advance the development of complex generics to improve patient access to medicines

FDA Commissioner on 2019 efforts to advance the development of complex generics to improve patient access to medicines
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on 2019 efforts to advance the development of complex generics to improve patient access to medicines

US FDA News: FDA approves first generic Advair Diskus

FDA approved the first generic of Advair Diskus for treatment of asthma and maintenance treatment of airflow obstruction and reducing exacerbations with COPD.
Read more: FDA approves first generic Advair Diskus

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on the agency’s efforts to enhance the utility of the Orange Book to foster drug competition

FDA announces new policies to ensure the Orange Book provides the greatest benefit to patients and providers, and generic drug developers.
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on the agency’s efforts to enhance the utility of the Orange Book to foster drug competition

Tuesday, January 29, 2019

Pharma Reviews: Gujarat focus sectors : Ports & Maritime

Gujarat produces 80 percent of the world's Isoniazid (used for treatment of tuberculosis) and 40 percent of India's machinery for pharma sector is ...
Read more: Gujarat focus sectors : Ports & Maritime

Monday, January 28, 2019

Product Recall Alerts: MediConnect: Blockchain Medicine and Drug Platform

Creates drug serial codes for registration on the blockchain; Issues drug recalls by deploying health warnings through the blockchain; Investigates the ...
Read more: MediConnect: Blockchain Medicine and Drug Platform

Pharma Reviews: We have to involve more interdisciplinary areas in combining resources to study sickle cell disease ...

There is a drug hydroxyurea that can reduce the frequency of crisis. ... Also, getting the attention of indigenous Indian pharma industry to develop ...
Read more: We have to involve more interdisciplinary areas in combining resources to study sickle cell disease ...

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., and Jeff Shuren, M.D., Director of the Center for Devices and Radiological Health, on a record year for device innovation

Review of 2018 device innovations, with record-setting 106 novel device approvals, and new actions FDA is taking to modernize approach to safety
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., and Jeff Shuren, M.D., Director of the Center for Devices and Radiological Health, on a record year for device innovation

Sunday, January 27, 2019

Pharma Reviews: Use compulsory license and put ceiling to curb prices of patented medicines: Government panel

The Indian pharmaceutical market has an annual turnover of around Rs 2.3 lakh crore. While majority of these revenues come from sales of generic ...
Read more: Use compulsory license and put ceiling to curb prices of patented medicines: Government panel

Friday, January 25, 2019

Pharma Reviews: Seminar urges TN government to evolve policy for pharma industry

Veeramani said that of the 1.2 trillion US dollars of global pharmaceutical market, India contributed to 34 billion US dollar worth pharmaceutical ...
Read more: Seminar urges TN government to evolve policy for pharma industry

Pharma Reviews: Indian pharma exports set to grow

Hyderabad: India is one of the top pharmaceuticals producing nation, which exports to over 180 countries. Pharmaceutical companies from India had ...
Read more: Indian pharma exports set to grow

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., and Janet Woodcock, M.D., director of the Center for Drug Evaluation and Research on the FDA’s ongoing investigation into valsartan and ARB class impurities and the agency’s steps to address the root causes of the safety issues

FDA describes the ongoing investigation into the ARB class impurities and agency’s steps to address the root causes of the safety issues
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., and Janet Woodcock, M.D., director of the Center for Drug Evaluation and Research on the FDA’s ongoing investigation into valsartan and ARB class impurities and the agency’s steps to address the root causes of the safety issues

Thursday, January 24, 2019

Pharma Reviews: NITI Aayog delegated NPPA role of drug price regulation

Indian pharmaceutical industry, rattled by the decision of former NPPA chairman Bhupendra Singh, who used special powers conferred under ...
Read more: NITI Aayog delegated NPPA role of drug price regulation

Pharma Reviews: The antacid effect: how Sun Pharma's pantoprazole bet gave it heartburn

The risk that burnt Sun PharmaIt was an exceptionally busy year for top Indian pharma companies, with homegrown generic drug makers having a ...
Read more: The antacid effect: how Sun Pharma's pantoprazole bet gave it heartburn

US FDA News: FDA statement from Commissioner Scott Gottlieb, M.D. announcing efforts to improve the quality of the information used to assess the effectiveness of REMS programs in supporting the safe use of medications

FDA describes new policies to ensure the safe use of medications
Read more: FDA statement from Commissioner Scott Gottlieb, M.D. announcing efforts to improve the quality of the information used to assess the effectiveness of REMS programs in supporting the safe use of medications

Wednesday, January 23, 2019

Pharma Reviews: India-Malta relations: Building bridges at the phoenician crossroads of Mediterranean

PM Muscat welcomed Indian Pharma and IT industry to make Malta a potential hub for African and European markets. He invited India to cooperate ...
Read more: India-Malta relations: Building bridges at the phoenician crossroads of Mediterranean

Pharma Reviews: Strong growth in India for the German glass conglomerate SCHOTT

One of most growing division for SCHOTT Group in India is its tubing division, ... Responsible pharmaceutical companies as well as the end users are ...
Read more: Strong growth in India for the German glass conglomerate SCHOTT

Pharma Reviews: CORRECTED-Morning News Call - India, January 23

Sun Pharma takes steps to ease governance concerns; shares rally India's top drugmaker by market value Sun Pharmaceutical Industries announced ...
Read more: CORRECTED-Morning News Call - India, January 23

US FDA News: FDA permits marketing of first test to aid in the diagnosis of a sexually-transmitted infection known as Mycoplasma genitalium

FDA permits marketing of first test to aid in the diagnosis of a sexually-transmitted infection known as Mycoplasma genitalium
Read more: FDA permits marketing of first test to aid in the diagnosis of a sexually-transmitted infection known as Mycoplasma genitalium

Product Recall Alerts: FDA: Another blood pressure drug under voluntary recall

The most recent FDA alert to patients and health care professionals is for a ... The FDA also updated the list of irbesartan products under recall.
Read more: FDA: Another blood pressure drug under voluntary recall

Tuesday, January 22, 2019

Pharma Reviews: Govt curbs on NPPA good, but distrust of the market is the real malaise

Continuing with a drug-price-capping regime, even with checks on the regulator's ... Though prices of most drugs in India are amongst the lowest in the ...
Read more: Govt curbs on NPPA good, but distrust of the market is the real malaise

Pharma Reviews: Drug pricing regime: Pharma companies express relief, health activists miffed

Indian pharmaceutical industry was rattled by the decision of former NPPA chairman Bhupendra Singh, who used special powers conferred under ...
Read more: Drug pricing regime: Pharma companies express relief, health activists miffed

Pharma Reviews: India presses China to import more Indian products to reduce trade deficit

BEIJING: India on Tuesday pressed China to import more Indian goods, especially pharmaceutical and IT products, as top commerce officials of the ...
Read more: India presses China to import more Indian products to reduce trade deficit

Pharma Reviews: Stocks in the news: Sun Pharma, Prabhat Dairy, L&T and Asian Paints

Asian Paints, ICICI Prudential: Asian Paints, Havells India, HDFC Standard Life Insurance Company, ICICI Prudential Life Insurance Company, Oberoi ...
Read more: Stocks in the news: Sun Pharma, Prabhat Dairy, L&T and Asian Paints

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D. and Jeff Shuren, M.D., Director of the Center for Devices and Radiological Health, on latest steps to strengthen FDA’s 510(k) program for premarket review of medical devices

FDA takes more steps toward strengthening 510(k) program for premarket review of medical devices
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D. and Jeff Shuren, M.D., Director of the Center for Devices and Radiological Health, on latest steps to strengthen FDA’s 510(k) program for premarket review of medical devices

Monday, January 21, 2019

Product Recall Alerts: Another Drug Company Recalls Tainted Sartan Products

As with some other recent sartan recalls, this latest one, announced January 18, stems from the finding of NDEA in the active pharmaceutical ...
Read more: Another Drug Company Recalls Tainted Sartan Products

Pharma Reviews: India, a vaccine production giant losing its trust?

Nearly half of all vaccines delivered globally are manufactured in India. This is a considerable accolade for India's pharmaceutical industry. Indian ...
Read more: India, a vaccine production giant losing its trust?

Pharma Reviews: Know 5 things before buying Sun Pharma shares

Here are the five things to consider before one invests in Sun Pharma: ... Sun Pharma is India's largest pharma company with a 8.3 per cent share of ...
Read more: Know 5 things before buying Sun Pharma shares

Pharma Reviews: 'Plastic' big issue for FMCG, pharma sectors as they depend on it for packaging

Foreign investors pressure and the urge to outwit competition will drive Indian consumer goods and pharma companies to change product packing to ...
Read more: 'Plastic' big issue for FMCG, pharma sectors as they depend on it for packaging

Pharma Reviews: Foreign investors to drive changes to green packaging: Report

MUMBAI, Jan 20: Foreign investors pressure and the urge to outwit competition will drive Indian consumer goods and pharma companies to change ...
Read more: Foreign investors to drive changes to green packaging: Report

Sunday, January 20, 2019

Pharma Reviews: Foreign investors to drive changes to green packaging: Report

Mumbai: Foreign investors pressure and the urge to outwit competition will drive Indian consumer goods and pharma companies to change product ...
Read more: Foreign investors to drive changes to green packaging: Report

Pharma Reviews: Lupin, Sun Pharma, Glenmark recall products in US

Indian drug majors Lupin, Sun Pharma and Glenmark Pharmaceuticals are recalling various drugs from the US market for a variety of reasons.
Read more: Lupin, Sun Pharma, Glenmark recall products in US

Saturday, January 19, 2019

Pharma Reviews: Geo politics to AI dominate agenda as PM Modi meets foreign leaders at Vibrant Gujarat Summit

Indian Pharma, IT industry especially Artificial Intelligence dominated talks between Malta's PM and PM Modi. Malta's PM invited India to cooperate ...
Read more: Geo politics to AI dominate agenda as PM Modi meets foreign leaders at Vibrant Gujarat Summit

Pharma Reviews: Geopolitics, AI dominate agenda as PM Modi meets 4 foreign leaders at Vibrant Gujarat

Uzbekistan's President and PM discussed the first India-Central Asia ... Indian Pharma, IT industry especially Artificial Intelligence (AI) dominated talks ...
Read more: Geopolitics, AI dominate agenda as PM Modi meets 4 foreign leaders at Vibrant Gujarat

Pharma Reviews: Reduction in provisioning helped few corporate banks report better profitability: Arun Thukral, MD ...

We believe that there is a sustainable growth ahead for the sector. Indian Pharma companies which are focusing on building complex and specialty ...
Read more: Reduction in provisioning helped few corporate banks report better profitability: Arun Thukral, MD ...

Pharma Reviews: India and Malta discuss possibility of enhancing commercial ties

Maltese PM Joseph Muscat, who is on his maiden visit to India, welcomed Indian Pharma and IT industry to make Malta a potential hub for African and ...
Read more: India and Malta discuss possibility of enhancing commercial ties

Pharma Reviews: India, Malta discuss possibility of enhancing trade, commercial ties

India and Malta discussed the possibility of enhancing trade and ... He welcomed Indian Pharma and IT industry to make Malta a potential hub for ...
Read more: India, Malta discuss possibility of enhancing trade, commercial ties

Thursday, January 17, 2019

Pharma Reviews: Indian pharma market grows 9.4% in 2018 led by medicines for chronic diseases

The Indian pharmaceutical market grew 9.4 percent year-on-year (YoY) to Rs 129,015 crore in 2018. The growth, much faster than 2017, was led by ...
Read more: Indian pharma market grows 9.4% in 2018 led by medicines for chronic diseases

Pharma Reviews: Podcast | Digging Deeper: Online pharmacies - Pill or poison?

India's pharma industry is nowhere near the size of, say, American style Big Pharma, but it certainly is expanding fast. According to India Brand Equity ...
Read more: Podcast | Digging Deeper: Online pharmacies - Pill or poison?

Pharma Reviews: Market Live: Indian indices recovers from lows with Nifty above 10900; pharma stocks under pressure

Results reaction: Share of Fibeweb India slipped 5.6 percent after company reported poor set of numbers for the quarter ended December 2018 ...
Read more: Market Live: Indian indices recovers from lows with Nifty above 10900; pharma stocks under pressure

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on unprecedented new efforts to support development of over-the-counter naloxone to help reduce opioid overdose deaths

FDA describes unprecedented new efforts to support development of over-the-counter naloxone to help reduce opioid overdose deaths
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on unprecedented new efforts to support development of over-the-counter naloxone to help reduce opioid overdose deaths

Wednesday, January 16, 2019

Pharma Reviews: Samurai sunrise: Japan's MUFG bank emerges as a new financier for India Inc's global mandates

The story is somewhat similar to when Aurobindo Pharma founder ... Industry estimates put MUFG's India business size at $13-14 billion, just by ...
Read more: Samurai sunrise: Japan's MUFG bank emerges as a new financier for India Inc's global mandates

Pharma Reviews: Vibrant Gujarat Summit: Pharma, environment MoUs to dominate

Vibrant Gujarat Summit: Pharma, environment MoUs to dominate ... Pharmaceuticals sector is likely to lead the table with business proposals worth Rs ... It will also partner with Indian Institute of Chemical Technology, Hyderabad for ...
Read more: Vibrant Gujarat Summit: Pharma, environment MoUs to dominate

US FDA News: FDA approves first generic version of Sabril to help treat seizures in adults and pediatric patients with epilepsy

FDA approved the first generic version of Sabril for treating complex partial seizures, as an adjunctive therapy in certain patients.
Read more: FDA approves first generic version of Sabril to help treat seizures in adults and pediatric patients with epilepsy

Tuesday, January 15, 2019

Pharma Reviews: Indoco in talks to sell part of India operations

Indoco's nine domestic marketing divisions cater to respiratory, ... Zydus and Lupin are looking to consolidate positions in the Indian market, while funds ... a $600-million exposure in Indian pharmaceuticals, including in Sun Pharma, ...
Read more: Indoco in talks to sell part of India operations

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D. and Peter Marks, M.D., Ph.D., Director of the Center for Biologics Evaluation and Research on new policies to advance development of safe and effective cell and gene therapies

FDA describes new policies to advance development of safe and effective cell and gene therapies
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D. and Peter Marks, M.D., Ph.D., Director of the Center for Biologics Evaluation and Research on new policies to advance development of safe and effective cell and gene therapies

Friday, January 11, 2019

Pharma Reviews: Expect a double digit growth in our Indian business: Murtaza Khorakiwala, Wockhardt

Pharma industry by and large has faced some headwinds in the past because of competition in the generic space in the US. In India, it was affected ...
Read more: Expect a double digit growth in our Indian business: Murtaza Khorakiwala, Wockhardt

Wednesday, January 9, 2019

Pharma Reviews: Closure of two production units won't impact India operations, says Pfizer

US pharma major Pfizer said it has a long-standing commercial and manufacturing presence in India for more than 60 years and the decision to shut ...
Read more: Closure of two production units won't impact India operations, says Pfizer

Pharma Reviews: Indian pharma industry records 9.4% growth in 2018, dispels GST gloom

The domestic pharmaceutical industry bounced back to a nearly double-digit year-on-year growth in 2018 (9.4 per cent), after falling to an eight-year ...
Read more: Indian pharma industry records 9.4% growth in 2018, dispels GST gloom

Pharma Reviews: India keen to reduce pharma imports from China

Hyderabad: India is the third largest pharmaceuticals producer in the world, yet, there is over dependency on China for certain active pharmaceutical ...
Read more: India keen to reduce pharma imports from China

Pharma Reviews: MSME pharma exporters get funding boost

Hyderabad: The Department of Commerce, Ministry of Commerce & Industry, Government of India, has revised the provisions relating to the 'Market ...
Read more: MSME pharma exporters get funding boost

Pharma Reviews: Policy changes/initiatives expected in healthcare sector in 2019

Invigorating policy framework to re-create the active pharmaceutical ingredient (API) backbone -One of the burning challenges in the Indian landscape ...
Read more: Policy changes/initiatives expected in healthcare sector in 2019

Pharma Reviews: Formulating the mid-year itch

Indian drug makers are crying foul over rising cost of inputs and lobbying hard with the Pharmaceutical Pricing Authority of India for a mid-year ...
Read more: Formulating the mid-year itch

Tuesday, January 8, 2019

Product Recall Alerts: A wave of drug recalls hits Indian pharma firms in US

In August last year, the pharmaceutical company also recalled around 109 lots of ... Drug products that contain NDMA or NDEA above the limits in the table ... Since September, the facility was put under an import alert, which stopped ...
Read more: A wave of drug recalls hits Indian pharma firms in US

Pharma Reviews: Ideas for Profit | This little-known Indian firm is a major Vitamin D ingredient producer

Sole manufacturer of Vitamin D3 API in India; significant global share ... As per pharma market research firm, AICOD AWACS, the domestic vitamin D3 ...
Read more: Ideas for Profit | This little-known Indian firm is a major Vitamin D ingredient producer

Pharma Reviews: Bengaluru to host pharma and medical devices conference on 18-19 Feb

Gowda will inaugurate the two-day event, which is India's biggest Global Conference on Pharma Industry and Medical Devices, and address the ...
Read more: Bengaluru to host pharma and medical devices conference on 18-19 Feb

Monday, January 7, 2019

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on the agency’s new actions under the Pre-Cert Pilot Program to promote a more efficient framework for the review of safe and effective digital health innovations

FDA issues three documents that launch next phase of Pre-Cert Pilot Program to test new approaches for the review of digital health device applications.
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on the agency’s new actions under the Pre-Cert Pilot Program to promote a more efficient framework for the review of safe and effective digital health innovations

Saturday, January 5, 2019

Pharma Reviews: DPCO amendment may benefit MNC device makers by allowing price control

Rajiv Nath, forum coordinator of the Association of Indian Medical Device Industry (AIMED), said that in order to allow any manufacturer or importer to ...
Read more: DPCO amendment may benefit MNC device makers by allowing price control

Pharma Reviews: Germ theory: How probiotic products are flying off the shelves

Indian pharma companies are, however, keen to make the most of the market. Suri of Morepen adds: “In the ethical market, probiotics are mostly ...
Read more: Germ theory: How probiotic products are flying off the shelves

Pharma Reviews: Drug companies turn to China, Japan after pricing pressure in west

HYDERABAD: Increasing price pressures in the North American market, which accounts for nearly a third of India's pharmaceutical exports, ...
Read more: Drug companies turn to China, Japan after pricing pressure in west

Product Recall Alerts: Hypertension drug recall expanded for cancer-causing impurity

For the second time this week, a recall alert has been issued for a drug that could contain a cancer-causing agent. A recall of Losartan potassium ...
Read more: Hypertension drug recall expanded for cancer-causing impurity

Product Recall Alerts: FDA: More Batches of Losartan Potassium, Blood Pressure Drug, Are Being Recalled

“Torrent is only recalling lots of losartan medication containing NDEA above the interim acceptable ... Zhejiang Huahai Pharmaceutical was also placed “on import alert” by the FDA earlier this year due to impurities in valsartan.
Read more: FDA: More Batches of Losartan Potassium, Blood Pressure Drug, Are Being Recalled

Product Recall Alerts: More Tainted Valsartan Products Recalled

Aurobindo Pharma USA has recalled 80 lots of medicines containing valsartan because of the presence of ... ZHP is the subject of an FDA import alert.
Read more: More Tainted Valsartan Products Recalled

Product Recall Alerts: Another blood pressure medication recalled over trace amounts of cancer-causing chemical

(CBSN) -- Another pharmaceutical company is recalling blood pressure medication after detecting trace amounts of a cancer-causing chemical.
Read more: Another blood pressure medication recalled over trace amounts of cancer-causing chemical

Friday, January 4, 2019

Pharma Reviews: Gearing up for tough bouts in an uncertain market

The operational environment for Indian drug companies will be challenging, given the market conditions in their two key markets, the US and India, ...
Read more: Gearing up for tough bouts in an uncertain market

Pharma Reviews: The India Pharma & India Medical Device 2019 Will Be held on the 18th & 19th in Bangalore

The India Pharma & India Medical Device 2019 Will Be held on the 18th ... He cited the example of single window clearance in the pharma sector, ...
Read more: The India Pharma & India Medical Device 2019 Will Be held on the 18th & 19th in Bangalore

Pharma Reviews: India's Biggest Global Conference of Pharma, Medical Devices to be Held on 18-19 Feb

India's biggest global conference on pharma industry and medical devices will be held on 18th and 19th February in Bengaluru. The event would ...
Read more: India's Biggest Global Conference of Pharma, Medical Devices to be Held on 18-19 Feb

Pharma Reviews: Bengaluru: India's Biggest Global Conference On Pharma, Medical Devices 2019 To Be Held On ...

The Department of Pharmaceuticals (DoP), Ministry of Chemicals and Fertilisers, and Federation of Indian Chambers of Commerce & Industry (FICCI) ...
Read more: Bengaluru: India's Biggest Global Conference On Pharma, Medical Devices 2019 To Be Held On ...

Thursday, January 3, 2019

Pharma Reviews: Bengaluru to host India Pharma & India Medical Device 2019

The event will see the participation of some of the biggest names in the Indian pharmaceutical and medical devices industry who will come together on ...
Read more: Bengaluru to host India Pharma & India Medical Device 2019

Pharma Reviews: Radiation doses differences in CT scans due to how scanners used by medical staff

“Endeavour of the Government is to provide affordable quality healthcare for all and boost indigenous pharma sector through 'Make in India'. In this ...
Read more: Radiation doses differences in CT scans due to how scanners used by medical staff

Pharma Reviews: Endeavour of govt is to provide affordable quality healthcare for all: Gowda

"The endeavour of the government is to provide affordable quality healthcare for all and boost indigenous pharma sector through 'Make in India'," ...
Read more: Endeavour of govt is to provide affordable quality healthcare for all: Gowda

Product Recall Alerts: Thousands MORE blood pressure pills are recalled because 'they contain a chemical used in ...

Regulators have recalled thousands more blood pressure pills from ... to not stop taking their medication, on the back of the new irbesartan alert.
Read more: Thousands MORE blood pressure pills are recalled because 'they contain a chemical used in ...

A large recall of valsartan medication was prompted in July after ... Zhejiang Huahai Pharmaceutical was also placed “on import alert” by the FDA ...
Read more: Blood Pressure Medication Valsartan, Manufactured by Aurobindo, Recalled Over Cancer ...

Product Recall Alerts: New year, new blood pressure medication recall: Drug tablets recalled over cancer concern

The U.S. Food and Drug Administration is alerting patients and health care professionals to another recall of medications used to treat high blood ...
Read more: New year, new blood pressure medication recall: Drug tablets recalled over cancer concern

As I have been saying for the last 12 months, the Indian market still remains .... there is a long overdue recovery in Indian pharma stocks as well.
Read more: Well-run smallcap companies will find 2019 a fertile year: Saurabh Mukherjea, Marcellus Investment

Pharma Reviews: ANDAs remain pillar of Indian pharma

The US Food and Drug Administration (FDA) has approved a record 741 generic drugs so far in the calendar 2018, with Indian pharma companies ...
Read more: ANDAs remain pillar of Indian pharma